Mangoceuticals, Inc.
MGRX· Nasdaq
MGRXMangoceuticals, Inc.
Filed Oct 27, 2023 · 10-Q · 27 days after period end · 0001493152-23-038526
| Metric | Q3 2023 | Q3 2022 |
|---|---|---|
| Revenue | $245.16K | — |
| Net Income | -$1.80M | -$994.92K |
| EPS Diluted | -$1.70 | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mangoceuticals, Inc. · CIK 1938046 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Oct 27, 2023 · 27 d after period end
